Matches in SemOpenAlex for { <https://semopenalex.org/work/W4328111540> ?p ?o ?g. }
Showing items 1 to 70 of
70
with 100 items per page.
- W4328111540 endingPage "138" @default.
- W4328111540 startingPage "123" @default.
- W4328111540 abstract "Introduction: Febuxostat belongs to Biopharmaceutical classification system (BCS) class II drugs, which have low solubility and high permeability. Amorphous solid dispersion is one of the techniques which can be useful to improve solubility and powder characteristics.
 Objective: To optimize the concentration of hydrophilic and hydrophobic polymers to improve the dissolution rate and solubility of febuxostat tablets.
 Methods: The amorphous solid dispersion of febuxostat was prepared by spray drying method using Kolliphor P237 (1:2). This amorphous solid dispersion was further used to compress the tablet. To improve solubility and dissolution rate, a full factorial design was applied to optimize the critical concentration of Kollidon SR and hydroxypropyl methyl cellulose (HPMC K4M). The prepared tablets were characterized by pre-compression and post-compression parameters.
 Result: The rate of drug release was sustained by formulating an amorphous solid dispersion technique. The optimized batch (FSRT-OB) was found to be fit for release average 93.30 % of the drug in sustain release manner up to 12hrs. The release kinetic data suggests that the drug release was controlled by combination of diffusion and chain relaxation mechanism. The optimized concentration for Kollidon SR and HPMC K4Mwas found to be 38.50 % and 7.72 % respectively.
 Conclusion: Amorphous solid dispersion technique is useful to enhance solubility, dissolution rate, and bioavailability of the Febuxostat tablet." @default.
- W4328111540 created "2023-03-22" @default.
- W4328111540 creator A5033258865 @default.
- W4328111540 creator A5049043254 @default.
- W4328111540 creator A5050087820 @default.
- W4328111540 date "2023-03-20" @default.
- W4328111540 modified "2023-10-18" @default.
- W4328111540 title "Enhancing the dissolution rate of poorly soluble drug Febuxostat using spray dried amorphous solid dispersion technique" @default.
- W4328111540 doi "https://doi.org/10.30827/ars.v64i2.27058" @default.
- W4328111540 hasPublicationYear "2023" @default.
- W4328111540 type Work @default.
- W4328111540 citedByCount "0" @default.
- W4328111540 crossrefType "journal-article" @default.
- W4328111540 hasAuthorship W4328111540A5033258865 @default.
- W4328111540 hasAuthorship W4328111540A5049043254 @default.
- W4328111540 hasAuthorship W4328111540A5050087820 @default.
- W4328111540 hasBestOaLocation W43281115401 @default.
- W4328111540 hasConcept C120665830 @default.
- W4328111540 hasConcept C121332964 @default.
- W4328111540 hasConcept C127413603 @default.
- W4328111540 hasConcept C155574463 @default.
- W4328111540 hasConcept C177562468 @default.
- W4328111540 hasConcept C178790620 @default.
- W4328111540 hasConcept C185592680 @default.
- W4328111540 hasConcept C192562407 @default.
- W4328111540 hasConcept C2779721657 @default.
- W4328111540 hasConcept C2779881121 @default.
- W4328111540 hasConcept C2780932893 @default.
- W4328111540 hasConcept C42360764 @default.
- W4328111540 hasConcept C43617362 @default.
- W4328111540 hasConcept C55493867 @default.
- W4328111540 hasConcept C56052488 @default.
- W4328111540 hasConcept C88380143 @default.
- W4328111540 hasConceptScore W4328111540C120665830 @default.
- W4328111540 hasConceptScore W4328111540C121332964 @default.
- W4328111540 hasConceptScore W4328111540C127413603 @default.
- W4328111540 hasConceptScore W4328111540C155574463 @default.
- W4328111540 hasConceptScore W4328111540C177562468 @default.
- W4328111540 hasConceptScore W4328111540C178790620 @default.
- W4328111540 hasConceptScore W4328111540C185592680 @default.
- W4328111540 hasConceptScore W4328111540C192562407 @default.
- W4328111540 hasConceptScore W4328111540C2779721657 @default.
- W4328111540 hasConceptScore W4328111540C2779881121 @default.
- W4328111540 hasConceptScore W4328111540C2780932893 @default.
- W4328111540 hasConceptScore W4328111540C42360764 @default.
- W4328111540 hasConceptScore W4328111540C43617362 @default.
- W4328111540 hasConceptScore W4328111540C55493867 @default.
- W4328111540 hasConceptScore W4328111540C56052488 @default.
- W4328111540 hasConceptScore W4328111540C88380143 @default.
- W4328111540 hasIssue "2" @default.
- W4328111540 hasLocation W43281115401 @default.
- W4328111540 hasLocation W43281115402 @default.
- W4328111540 hasOpenAccess W4328111540 @default.
- W4328111540 hasPrimaryLocation W43281115401 @default.
- W4328111540 hasRelatedWork W1976019421 @default.
- W4328111540 hasRelatedWork W2365541608 @default.
- W4328111540 hasRelatedWork W2366838512 @default.
- W4328111540 hasRelatedWork W2388379895 @default.
- W4328111540 hasRelatedWork W2589082975 @default.
- W4328111540 hasRelatedWork W2802813041 @default.
- W4328111540 hasRelatedWork W3042724307 @default.
- W4328111540 hasRelatedWork W3135960659 @default.
- W4328111540 hasRelatedWork W3193802286 @default.
- W4328111540 hasRelatedWork W2184891667 @default.
- W4328111540 hasVolume "64" @default.
- W4328111540 isParatext "false" @default.
- W4328111540 isRetracted "false" @default.
- W4328111540 workType "article" @default.